Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
22M
-
Number of holders
-
38
-
Total 13F shares, excl. options
-
6.24M
-
Shares change
-
+124K
-
Total reported value, excl. options
-
$22.4M
-
Value change
-
+$385K
-
Put/Call ratio
-
5.41
-
Number of buys
-
14
-
Number of sells
-
-16
-
Price
-
$3.59
Significant Holders of EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) as of Q1 2025
46 filings reported holding XGN - EXAGEN INC. - Common Stock, par value $0.001 per share as of Q1 2025.
EXAGEN INC. - Common Stock, par value $0.001 per share (XGN) has 38 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 6.24M shares
of 22M outstanding shares and own 28.3% of the company stock.
Largest 10 shareholders include RTW INVESTMENTS, LP (1.51M shares), TORONTO DOMINION BANK (891K shares), SILVERCREST ASSET MANAGEMENT GROUP LLC (532K shares), VANGUARD GROUP INC (491K shares), MORGAN STANLEY (486K shares), PERKINS CAPITAL MANAGEMENT INC (423K shares), Driehaus Capital Management LLC (419K shares), KENNEDY CAPITAL MANAGEMENT LLC (295K shares), Hudson Bay Capital Management LP (167K shares), and RENAISSANCE TECHNOLOGIES LLC (137K shares).
This table shows the top 38 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.